Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2,4-diamino-5-(6-methylveratryl)pyrimidine
1. 6981-18-6
2. Ormethoprim
3. Ormetorprim
4. 2,4-diamino-5-(6-methylveratryl)pyrimidine
5. Ro 5-9754
6. Component Of Rofenaid
7. Ormetroprim
8. 5-[(4,5-dimethoxy-2-methylphenyl)methyl]pyrimidine-2,4-diamine
9. 2,4-pyrimidinediamine, 5-[(4,5-dimethoxy-2-methylphenyl)methyl]-
10. 5-(4,5-dimethoxy-2-methylbenzyl)-2,4-diaminopyrimidine
11. 5-(4,5-dimethoxy-2-methylbenzyl)pyrimidine-2,4-diamine
12. Nsc-95072
13. M3efs94984
14. Nsc95072
15. Ro-59754
16. Ncgc00167523-01
17. Ormetoprim 100 Microg/ml In Acetonitrile
18. Ro-5-9754
19. 2,4-pyrimidinediamine, 5-((4,5-dimethoxy-2-methylphenyl)methyl)-
20. Dsstox_cid_26689
21. Dsstox_rid_81823
22. Dsstox_gsid_46689
23. Ormetoprima
24. Ormetoprime
25. Ormetoprimum
26. 5-[(4,5-dimethoxy-2-methyl-phenyl)methyl]pyrimidine-2,4-diamine
27. Smr000466374
28. Cas-6981-18-6
29. Ormetoprim [usan:inn]
30. Nsc 95072
31. Ormetoprime [inn-french]
32. Ormetoprimum [inn-latin]
33. Ormetoprima [inn-spanish]
34. Unii-m3efs94984
35. Einecs 230-246-6
36. Ormetoprim [inn]
37. Ormetoprim [jan]
38. Ormetoprim (usan/inn)
39. Ormetoprim [usan]
40. Ormetoprim [mart.]
41. Pyrimidine, 2,4-diamino-5-(6-methylveratryl)-
42. Nciopen2_006334
43. Schembl93810
44. Zinc562
45. Mls000759503
46. Mls001424067
47. Chembl494760
48. Ormetoprim [green Book]
49. 2,4-diamino-5-(4,5-dimethoxy-2-methylbenzyl)pyrimidin
50. Dtxsid1046689
51. Chebi:94553
52. Cv564
53. Hms2051k20
54. Hms3393k20
55. Bcp06018
56. Tox21_112520
57. Bdbm50413401
58. Mfcd00057747
59. S5290
60. Akos015917221
61. Tox21_112520_1
62. Ccg-100900
63. Nc00150
64. Sb60507
65. Ncgc00167523-02
66. Ncgc00167523-03
67. As-71719
68. Bo164180
69. Db-055351
70. Hy-121466
71. Sd-051044
72. Am20041036
73. Cs-0082144
74. Ft-0630358
75. O0424
76. Pyrimidine,4-diamino-5-(6-methylveratryl)-
77. D05273
78. T72844
79. 2, 5-[(4,5-dimethoxy-2-methylphenyl)methyl]-
80. Ab00639990-08
81. 981o186
82. A836658
83. W-104583
84. Q27166391
85. 2,4-diamino-5-(4,5-dimethoxy-2-methylbenzyl)pyrimidine
86. 5-(4,5-dimethoxy-2-methylbenzyl)-2,4-pyrimidinediamine
87. 2,4-diamino-5-(4,5-dimethoxy-2-methylbenzyl) Pyrimidine
88. 5-(4,5-dimethoxy-2-methyl-benzyl)-pyrimidine-2,4-diamine
Molecular Weight | 274.32 g/mol |
---|---|
Molecular Formula | C14H18N4O2 |
XLogP3 | 1.2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 4 |
Exact Mass | 274.14297583 g/mol |
Monoisotopic Mass | 274.14297583 g/mol |
Topological Polar Surface Area | 96.3 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 305 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
NDC Package Code : 69169-113
Start Marketing Date : 2016-12-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?